Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.
D000368:Aged; D001712:Biperiden / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003024:Clozapine / Q000009:adverse effects*; D003984:Dibenzazepines / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010880:Piperidines / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy; D013881:Thioridazine / Q000009:adverse effects*
D003984:Dibenzazepines; D010880:Piperidines; D001712:Biperiden; D003024:Clozapine; D006220:Haloperidol; D013881:Thioridazine